Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
VEON
VEON
$3.92B
| $8.18M | 0.02% |
25,284
-12,848
| -34% | -$4.11M |
|
902
Canadian Pacific Kansas City
CP
$81.5B
| $8.15M | 0.02% |
269,500
-1,050,000
| -80% | -$30.3M |
|
|
CMLP
903
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
| $8.15M | 0.02% |
+327,352
| New | +$7.28M |
|
|
HILL
904
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $8.11M | 0.02% |
2,406,500
+72,700
| +3% | +$202K |
|
905
Quanta Services
PWR
$102B
| $8.08M | 0.02% |
256,099
-7,500
| -3% | -$220K |
|
906
Regis Corp
RGS
$69.3M
| $8.02M | 0.02% |
27,650
-760
| -3% | -$228K |
|
907
Scorpio Tankers
STNG
$3.81B
| $8.02M | 0.02% |
68,050
+7,770
| +13% | +$871K |
|
908
NiSource
NI
$20.1B
| $8M | 0.02% |
619,453
-2,222,549
| -78% | -$27.6M |
|
|
ALR
909
DELISTED
AlerisLife Inc
ALR
| $7.98M | 0.02% |
145,290
+12,310
| +9% | +$624K |
|
|
IMOS
910
ChipMOS TECHNOLOGIES
IMOS
$1.96B
| $7.95M | 0.02% |
375,175
+156,005
| +71% | +$3.12M |
|
911
Strategic Education
STRA
$1.81B
| $7.95M | 0.02% |
230,600
-105,600
| -31% | -$4.09M |
|
|
PCTI
912
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $7.95M | 0.02% |
830,300
+23,100
| +3% | +$218K |
|
913
Kaiser Aluminum
KALU
$2.99B
| $7.94M | 0.02% |
113,100
+57,400
| +103% | +$3.93M |
|
914
Southern Copper
SCCO
$165B
| $7.94M | 0.02% |
301,795
-769,946
| -72% | -$19.1M |
|
|
LHO
915
DELISTED
LaSalle Hotel Properties
LHO
| $7.87M | 0.02% |
+254,900
| New | +$7.79M |
|
|
AFSI
916
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $7.86M | 0.02% |
481,012
+434,400
| +932% | +$8.22M |
|
|
HNT
917
DELISTED
HEALTH NET INC
HNT
| $7.85M | 0.02% |
264,700
-515,100
| -66% | -$15.4M |
|
918
MasTec
MTZ
$22.6B
| $7.85M | 0.02% |
239,900
+201,500
| +525% | +$6.38M |
|
|
NSU
919
DELISTED
Nevsun Resources Ltd.
NSU
| $7.85M | 0.02% |
2,364,400
+352,300
| +18% | +$1.17M |
|
920
Idexx Laboratories
IDXX
$45B
| $7.82M | 0.02% |
147,104
-90,296
| -38% | -$4.75M |
|
|
HOS
921
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $7.82M | 0.02% |
158,900
-101,900
| -39% | -$5.41M |
|
|
VIA
922
DELISTED
Viacom Inc. Class A
VIA
| $7.82M | 0.02% |
89,050
+12,900
| +17% | +$1.07M |
|
|
MDP
923
DELISTED
Meredith Corporation
MDP
| $7.81M | 0.02% |
150,800
-125,200
| -45% | -$6.39M |
|
924
Clearfield
CLFD
$395M
| $7.81M | 0.02% |
385,834
-17,365
| -4% | -$290K |
|
925
Fomento Económico Mexicano
FMX
$40B
| $7.8M | 0.02% |
79,700
-178,700
| -69% | -$16.8M |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.